Ekinadese Aburime

Ekinadese Aburime practices at Piedmont Rockdale in Conyers, Georgia, part of Piedmont Healthcare.

Ekinadese Aburime's NPI, 1265693873, was assigned on June 17, 2008. Ekinadese Aburime holds Georgia license 076760.

Ekinadese Aburime's primary practice is Piedmont Rockdale, at 1412 Milstead Avenue, NE, Conyers, GA 30012 in Rockdale County. The practice phone is (770) 918-3000.

Ekinadese Aburime's primary practice is Piedmont Rockdale in Conyers, Georgia, part of Piedmont Healthcare. Ekinadese Aburime is also affiliated with Piedmont Henry Hospital. The medical group on file is Piedmont Physicians Obstetrics and Gynecology of Jasper. Dmand AI also links Ekinadese Aburime to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ekinadese Aburime practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Ekinadese Aburime's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Ekinadese Aburime is licensed in Georgia.

CMS data shows 863 Medicare services from Ekinadese Aburime across 16 procedure codes in 2024, for 325 Medicare patients. Medicare paid $85,974 for them.

CMS counts 325 Medicare patients who saw Ekinadese Aburime in 2024. The largest group is 65 to 74, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ekinadese Aburime's median patient age at 61, with 62% women.

In 2024, Ekinadese Aburime wrote 728 Medicare Part D claims for 243 patients. 80% of them were for generic drugs. CMS names the drug for 600 of them, across 15 drugs with 11 or more claims each, at $214,396 in total drug cost. In 2023, CMS named 639 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Ekinadese Aburime for performance year 2024, reported through an alternative payment model (APM). Ekinadese Aburime accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ekinadese Aburime as offering telehealth. CMS counts 347 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Ekinadese Aburime, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Ekinadese Aburime. Ekinadese Aburime's most frequent co-authors are Akwi Wasi Asombang, MD and Kulwinder S. Dua, MD.

CMS Open Payments shows 269 general payments to Ekinadese Aburime from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 42% of the total. CONMED Corporation paid the most, $5,640.